Pricing

Biodelivery Sciences International Inc (BDSI)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Mark A. Sirgo
Employees:
164
4131 PARKLAKE AVENUE, SUITE 225, RALEIGH, NC, 27612
919 582 9050

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

BioDelivery Sciences International, Inc. engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available